These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22810273)

  • 1. Robust inference in discrete hazard models for randomized clinical trials.
    Nguyen VQ; Gillen DL
    Lifetime Data Anal; 2012 Oct; 18(4):446-69. PubMed ID: 22810273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of treatment effects based on possibly misspecified Cox regression.
    Hattori S; Henmi M
    Lifetime Data Anal; 2012 Oct; 18(4):408-33. PubMed ID: 22527680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
    Rauch G; Brannath W; Brückner M; Kieser M
    Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instrumental variable with competing risk model.
    Zheng C; Dai R; Hari PN; Zhang MJ
    Stat Med; 2017 Apr; 36(8):1240-1255. PubMed ID: 28064466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential tests for non-proportional hazards data.
    Brückner M; Brannath W
    Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptotically robust variance estimation for person-time incidence rates.
    Scosyrev E
    Biom J; 2016 May; 58(3):474-88. PubMed ID: 26439107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size and robust marginal methods for cluster-randomized trials with censored event times.
    Zhong Y; Cook RJ
    Stat Med; 2015 Mar; 34(6):901-23. PubMed ID: 25522033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hazard ratio estimation and inference in clinical trials with many tied event times.
    Mehrotra DV; Zhang Y
    Stat Med; 2018 Nov; 37(25):3547-3556. PubMed ID: 29900572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
    Zhao L; Tian L; Uno H; Solomon SD; Pfeffer MA; Schindler JS; Wei LJ
    Clin Trials; 2012 Oct; 9(5):570-7. PubMed ID: 22914867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed discrete and continuous Cox regression model.
    Prentice RL; Kalbfleisch JD
    Lifetime Data Anal; 2003 Jun; 9(2):195-210. PubMed ID: 12735496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent and robust inference in hazard probability and odds models with discrete-time survival data.
    Tan Z
    Lifetime Data Anal; 2023 Jul; 29(3):555-584. PubMed ID: 36562895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric Bayesian analysis of censored linear regression with errors-in-covariates.
    Sinha S; Wang S
    Stat Methods Med Res; 2017 Jun; 26(3):1389-1415. PubMed ID: 25882297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Cox analysis of a randomized survival study yield a causal treatment effect?
    Aalen OO; Cook RJ; Røysland K
    Lifetime Data Anal; 2015 Oct; 21(4):579-93. PubMed ID: 26100005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of multivariate interval-censored survival data.
    Kim MY; Xue X
    Stat Med; 2002 Dec; 21(23):3715-26. PubMed ID: 12436466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inference for the proportional hazards model with misclassified discrete-valued covariates.
    Zucker DM; Spiegelman D
    Biometrics; 2004 Jun; 60(2):324-34. PubMed ID: 15180657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.